Pharmacogenomic testing-based precision medicine in the elderly: Current status and prospects
10.3760/cma.j.issn.0254-9026.2022.09.022
- VernacularTitle:药物基因组学检测指导老年精准用药的现状与展望
- Author:
Yuyan WANG
1
;
Tong YIN
;
Li FAN
Author Information
1. 国家老年疾病临床医学研究中心中国人民解放军总医院第二医学中心，北京 100000
- Keywords:
Pharmacogenetic testing;
Improper use of drugs;
Precision medicine
- From:
Chinese Journal of Geriatrics
2022;41(9):1126-1129
- CountryChina
- Language:Chinese
-
Abstract:
Comorbidities will inevitably lead to an increase in the number of medications used and adverse drug reaction events in elderly patients.Therefore, it is urgent to implement precision medicine in the elderly population.pharmacogenomic testing can increase the opportunity of individualized drug selection for elderly patients, reduce the risk of adverse drug reactions, reduce the cost-effectiveness ratio of medication, improve elderly patients' medication compliance, and thus reduce their readmission rate.Therefore, it is necessary to promote pharmacogenetic testing for elderly patients with comorbidities and polypharmacy, so as to provide measures for the implementation of personalized medicine in the elderly.
